Leilani Townsend, DO
Dermatology · University Place, WANPI 1215265079
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 370 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 27.9% of the total.
Across 370 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Galderma Laboratories, L.p.$423
- Novartis$396
- Sanofi$382
- Lilly USA, LLC$360
- plus $2K from 20 others
What the payments were for
- Food & beverage$7,23897%
- Education$2233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $2,078 |
| Johnson & Johnson | 83 | $1,605 |
| Galderma Laboratories, L.p. | 22 | $423 |
| Novartis | 20 | $396 |
| Sanofi | 18 | $382 |
| Lilly USA, LLC | 21 | $360 |
| Regeneron Healthcare Solutions, Inc. | 16 | $321 |
| Sun Pharmaceutical Industries Inc. | 16 | $252 |
| Merz North America, Inc. | 6 | $243 |
| Incyte Corporation | 9 | $238 |
| UCB, Inc. | 9 | $208 |
| Amgen | 9 | $200 |
| Pfizer | 9 | $182 |
| Arcutis Biotherapeutics, Inc. | 6 | $97 |
| E.r. Squibb & Sons, L.L.C. | 4 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $58 |
| Biofrontera Inc. | 3 | $54 |
| Mayne Pharma Commercial LLC | 3 | $52 |
| LEO Pharma Inc. | 2 | $44 |
| Dermavant Sciences, Inc. | 2 | $41 |
| Organon | 2 | $38 |
| Genentech USA, Inc. | 1 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bristol Myers Squibb | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
How this compares
$7,461 in reported general payments places this provider in the 85th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $44,428 |
| Calcipotriene | 54 | $7,337 |
| Ketoconazole | 360 | $6,703 |
| Fluorouracil | 59 | $5,802 |
| Azelaic Acid | 35 | $4,349 |
| Clobetasol Propionate | 127 | $4,307 |
| Tacrolimus | 26 | $4,302 |
| Fluocinonide | 68 | $3,009 |
| Mupirocin | 157 | $1,321 |
| ValacyclovirValacyclovir Hcl | 44 | $1,136 |
| Metronidazole | 22 | $1,005 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 17 | $964 |
| Triamcinolone Acetonide | 134 | $895 |
| Hydrocortisone | 158 | $740 |
| Clindamycin Phosphate | 18 | $734 |
Paid to pharmacies, not to this prescriber.
Other dermatology in University Place
- Kimberly WennerUniversity Place$6K
- Clive LiuBellevue$2.9M
- Vivian ShiSeattle$971K
- William WerschlerSpokane$948K
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Ting-Lin YangBellingham$124K
- James CollyerSeattle$115K
- Cameron ChesnutSpokane$93K
- Alison YoungSeattle$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.